Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

50.50 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2 3 4 5 Next >

Why Pulse Biosciences Stock Popped Today ↗

September 09, 2026

The medical device maker now has a new bull touting its growth potential.

Via The Motley Fool

Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform ↗

August 16, 2026

Pulse Biosciences (NASDAQ:PLSE) is positioning its nanosecond pulsed field ablation technology as a potential next-generation treatment platform for atrial fibrillation and other conditions, President,...

Via MarketBeat

Topics Intellectual Property

Pulse Biosciences (PLSE) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

NANOPULSE-AF enrollment hit halfway point ahead of schedule with 82 patients.

Via The Motley Fool

Topics Earnings

Pulse Biosciences Inc (NASDAQ:PLSE) Narrows Q4 Loss, Beats Revenue Estimates ↗

February 19, 2026

Via Chartmill

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024 ↗

August 22, 2024

Pulse Biosciences just reported results for the second quarter of 2024.

Via InvestorPlace

Pulse Biosciences Q2 Earnings Call Highlights ↗

August 07, 2026

Pulse Biosciences (NASDAQ:PLSE) reported second-quarter revenue of $434,000 as it accelerated clinical development of its nanosecond pulsed field ablation, or nsPFA, technology, particularly for atrial...

Via MarketBeat

Topics Earnings Intellectual Property

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors. ↗

May 17, 2026

Pulse Biosciences, a developer of non-thermal bioelectric treatments, reported a notable insider buy amid recent stock price gains.

Via The Motley Fool

Topics Regulatory Compliance

Pulse Biosciences Q1 Earnings Call Highlights ↗

May 08, 2026

Pulse Biosciences (NASDAQ:PLSE) said it is sharpening its focus on its nanosecond pulsed field ablation platform for atrial fibrillation after reporting first-quarter 2026 results and highlighting new...

Via MarketBeat

Topics Earnings

PLSE Q1 2026 Earnings Transcript ↗

May 08, 2026

PLSE Q1 2026 Earnings Transcript

Via The Motley Fool

Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript ↗

May 04, 2026

Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript

Via The Motley Fool

PLSE Q4 2025 Earnings Transcript ↗

May 04, 2026

PLSE Q4 2025 Earnings Transcript

Via The Motley Fool

Topics Intellectual Property

These stocks have an unusual volume in today's session ↗

February 12, 2026

Via Chartmill

These stocks are moving in today's session ↗

February 06, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

February 06, 2026

Via Chartmill

Pulse Biosciences (PLSE) Earnings Transcript ↗

November 06, 2025

Pulse Biosciences (PLSE) Earnings Transcript

Via The Motley Fool

Pulse Biosciences Cash Jumps in Q2 ↗

August 12, 2025

Via The Motley Fool

Topics Intellectual Property

Pulse Biosciences Inc (NASDAQ:PLSE) Reports Q2 2025 Earnings: Wider Loss, Clinical Progress in Focus ↗

August 12, 2025

Pulse Biosciences reported a Q2 2025 net loss of $0.28 per share, slightly wider than estimates, with no revenue. The company advances its nsPFA tech in clinical trials, focusing on atrial fibrillation...

Via Chartmill

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

April 02, 2025

The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 01, 2024

Via Benzinga

Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday ↗

August 13, 2024

Via Benzinga

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns ↗

July 12, 2024

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-than-expected June inflation data and potential interest rate cuts.

Via Benzinga

Topics Economy

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 08, 2024

Via Benzinga

S&P 500, Nasdaq Extend Record Highs; Dow Up Triple Digits ↗

July 08, 2024

The Dow Jones Industrial Average is up triple digits midday, as investors look ahead to this week's inflation data.

Via Talk Markets

Topics Economy Stocks

Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday ↗

July 08, 2024

Via Benzinga

Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 31, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.